Metraipolis › archive › dc_4483babe558e

Development and Immune Efficacy Evaluation of Two Live Triple-Gene-Deleted Vaccine Candidates Against Bovine Herpesvirus Type 1 — Europe PMC PMID:42278041

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42278041
DOI
10.3390/ani16111606
License (as archived)
solo-consultazione
Archived
2026-11-01T08:19:30.366Z
SHA-256 of the archived text
b17529d645b8d8878f3562e3eff94920f9b788ba3a55e634b3af399fdc390c32
Stable URL of this page
https://metraipolis.com/documento/dc_4483babe558e

How to cite

Development and Immune Efficacy Evaluation of Two Live Triple-Gene-Deleted Vaccine Candidates Against Bovine Herpesvirus Type 1 — Europe PMC PMID:42278041 — Europe PMC (en), https://europepmc.org/article/MED/42278041 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4483babe558e (Metraipolis archive dc_4483babe558e, sha256 b17529d645b8d8878f3562e3eff94920f9b788ba3a55e634b3af399fdc390c32)
BibTeX
@misc{dc4483babe558e,
  title = {Development and Immune Efficacy Evaluation of Two Live Triple-Gene-Deleted Vaccine Candidates Against Bovine Herpesvirus Type 1 — Europe PMC PMID:42278041},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42278041},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4483babe558e; sha256 b17529d645b8d8878f3562e3eff94920f9b788ba3a55e634b3af399fdc390c32},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42278041. Agents can read the archived copy with the MCP tool read_document.